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Abstract: The aim of this work was to study the influence of the different synthesis processes on
microstructural and morphological characteristics and distribution of hydroxyapatite-bioactive glass
(HAp-BG) composite nanopowders obtained by sol–gel method. HAp-BG composite nanopowders
with 20 wt% bioactive glass were prepared using a sol–gel method via four routes: (I) mixing the
prepared HAp solution with BG solution before aging time; (II) mixing the prepared BG solution with
the prepared HAp gel after gelation; (III) mixing the calcined BG nanopowders with the prepared
HAp solution; and (IV) mixing the two prepared calcined nanopowders by mechanochemical
activation. The prepared nanopowders were evaluated and studied by X-ray diffraction (XRD),
scanning electron microscopy (SEM), energy dispersive X-ray spectrometer (EDS), Fourier transform
infrared (FTIR), transmission electron diffraction (TEM) and Brunauer–Emmet–Teller (BET) method
to investigate the phase structure, microstructure and morphology, functional groups, and the size and
distribution of nanopowders. Results indicated that morphology, crystallinity, crystallite size and
specific surface area (SSA) of the powders are highly correspondent to the process and type of
synthesis method. These findings suggest that the modified sol–gel derived HAp-BG composite
nanopowders are expected to efficiently provide a possibility to produce a good candidate to use for
fabrication of a bulk nanostructured HAp-BG composite for bone tissue engineering.
Keywords: hydroxyapatite (HAp); bioactive glass (BG); composite; nanopowders; sol–gel

1 Introduction
The hard tissues of bones are composed of calcium

* Corresponding author.
E-mail: mht.taherian@hotmail.com

phosphate minerals which play vital roles during bone
metabolism. These inorganic minerals mechanically
support the body and provide the essential ions into the
body fluids to maintain homeostasis [1]. A great deal
of research has shown that calcium phosphates and
their derivatives (such as hydroxyapatite) can provide a
desirable environment for bone tissue regeneration due
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to their similarity in chemistry to natural bone, enamel
and dentine [2]. Due to the large surface area to
volume ratio of nanometer-sized particles, it has been
found that nanostructured biomaterials increase
mechanical reliability, osteoblast cell adhesion,
proliferation and mineralization compared with their
conventional micron-scale counterparts [3,4].
A major component of the inorganic part of natural
bone is composed of nanostructured hydroxyapatite
(HAp, Ca10(PO4)6(OH)2)) crystals of approximately
50 nm in length and 5 nm in diameter [2]. A successful
bone regeneration of the applied biomaterials depends
on the cell proliferation, differentiation and
mineralization of the extracellular matrix [5].
Nanostructured HAp interacts with osteoblast cells and
mimics the structure of the natural extracellular matrix.
Moreover, research has shown that the nanocrystalline
HAp enhances osteoblast adhesion and proliferation
compared to conventional micron-sized HAp [6].
However, medical applications of HAp have been
limited because of its low mechanical properties and
slow rate of osseointegration [7]. Ideal orthopedic
biomaterials should improve the mechanical properties
and bioactivity during implantation. Currently,
bioactive glass and hydroxyapatite are two main
bioactive materials for bone regeneration therapies [8].
Incorporation of bioactive glass (BG) particles
endows particular properties to HAp, such as
improving bioactivity and mechanical properties [9].
The certain composition of bioactive glasses
containing SiO2–CaO–P2O5 has found wide
applications as bone implants [10]. Results of in vivo
implantation show that these compositions bond to
tissues without an intervening fibrous layer and
produce no local or systemic toxicity [11]. Introduction
of silicate ions into the HAp structure improves in vivo
bioactivity and induces both osteogenesis and
angiogenesis during bone regeneration [7,12].
Recently, sol–gel technique as a wet chemical
method has been widely applied for synthesis of
bioceramic nanopowders. The crystalline degree and
morphology of the sol–gel derived nanopowders can
be controlled by a number of parameters including the
intrinsic properties of the solution (e.g., the type of
bioceramics, the conformation of bioceramic
concentration) and the operational conditions (e.g., the
hydrolysis time, the sequence of reactions) [13,14].
The aim of present research was to evaluate and
compare the effect of different synthesis processes on
microstructural and morphological characteristics and

distribution
of
hydroxyapatite-bioactive
glass
(HAp-BG) composite nanopowders obtained by
sol–gel method. Based on the obtained results, the
optimum process of the preparation could be
introduced.

2 Materials and methods
2. 1

Powder preparation

The preparation of the sol–gel derived HAp and
bioactive glass powders was slightly modified from
our previous works and published reports [15–17]. In
brief, as sol–gel precursors for HAp, calcium nitrate
tetrahydrate (Ca(NO3)2·4H2O, Merck) and phosphoric
pentoxide (P2O5, Merck) were used. Both were
hydrolyzed separately in ethanol (Et(OH), Merck), and
then mixed at a Ca/P ratio of 1.67, and stirred for 2 h.
The mixture was continuously stirred for 24 h at
ambient temperature. This process was called aging.
The gel was dried at 80 ℃ for 24 h.
The bioactive glass was prepared with the nominal
composition (in mol%) of 46.1%SiO2–51.3%CaO–
2.6%P2O5 by hydrolysis and polycondensation
reactions of chemicals using reagent-grade tetraethyl
orthosilicate (TEOS, Si(OC2H5)4, Merck), triethyl
phosphate (TEP, OP(OC2H5)3, Merck), calcium nitrate
tetrahydrate (Ca(NO3)2·4H2O, Merck), ethanol
(Et(OH), Merck), hydrochloric acid (HCl, Merck) and
deionized distilled water. The molar ratio of each
compound was adjusted according to the molar ratio of
SiO2, P2O5 and CaO within the designed bioactive
glass. The precursors were added in sequence and
stirred for at least 2 h to prepare a clear solution. The
resulting gel was aged at 60 ℃ for 48 h and dried at
120 ℃ for 48 h.
The HAp-BG composite nanopowders were
prepared using 20 wt% bioactive glass as
reinforcement within the HA matrix by the following
different routes:
(I) Mixing HAp solution with BG solution before
aging time (HBI);
(II) Mixing BG solution with HAp gel after gelation
(HBII);
(III) Mixing calcined BG nanopowders with HAp
solution (HBIII);
(IV) Mixing calcined HAp and BG powders by
mechanochemical activation (HBIV).
The HBIV sample was produced using a
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high-energy planetary ball mill (PM 100, Retsch,
Germany) with a zirconia vial and zirconia balls via
2 h mechanochemical activation to produce more
homogenous composite nanopowders. Figure 1
outlines the experimental procedure of the present
study.
2. 2

Powder characterization

Structural changes of the samples (phase composition,
crystallinity and crystallite size) were studied by X-ray
diffraction analysis (XRD, Philips Xpert, the
Netherlands) with Cu Kα radiation (λ = 0.15406 nm,
radiation at 40 kV and 30 mA) over the 2θ range of
20°–70° at a scan rate of 0.02 (°)/s. The obtained
experimental patterns were compared to standards
compiled by the Joint Committee on Powder
Diffraction and Standards (JCDPS), which involved
Card No. 9-432 for HAp. The fractions of crystalline
phase of HAp in each sample were evaluated using the
following equation [18]:
X c  1  V112/300 / I 300
(1)
where I 300 is the intensity of the diffraction peak (300)
and V112/300 is the intensity of the hollow between
diffraction peaks (112) and (300) of HAp phase. The
size of the HAp crystallites responsible for the Bragg
reflection of the (002) and (300) planes was
determined using the well-known Scherrer’s equation
[19]:
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X s  k  /( B cos  )

(2)

where X s is the crystallite diameter (nm); k ,  , B
and  are the shape constant (k = 0.89), the
wavelength of X-ray beam (  = 1.5418 Å for Cu Kα
radiation), the full width at half maximum for the
diffraction peak (radian), and the diffraction angle
(degree), respectively.
The functional groups and chemical structure of the
prepared powders were determined by Fourier
transform-infrared spectroscopy (FTIR, Jasco-680,
Japan). The IR spectra were run on KBr pellets, with a
weight ratio of sample to KBr of 1:100. The spectrum
was recorded in the range of 4000–400 cm−1 with a
resolution of 1 cm−1.
The microstructural features and elemental chemical
composition of the powders were studied by scanning
electron microscopy (SEM, Phillips XL30) attached
with an energy dispersive X-ray spectroscopy (EDS,
Seron Technology AIS 2300C, Korea) and an image
analyzer software (ImageJ, National Institutes of
Health, Bethesda, MD, USA).
The morphology and particle size distribution of the
powders were carried out by transmission electron
microscopy (TEM, LEO 912 AB, Ziess, Germany) in
bright field mode, with the accelerating voltage being
120 kV.
The specific surface area (SSA) of the ceramic
powders was calculated according to Brunauer–
Emmet–Teller (BET) method using Micromeritics
Device (Norcross, USA).
The primary particle size ( DBET ) was estimated by
assuming the particles to be spherical [20]:
DBET  6/( ρS )

(3)

where ρ is the theoretical density of the sample, and
S is the SSA. The ρ value was determined by a
precise pycnometeric method according to ASTM
D854.

3
3. 1

Fig. 1 Schematic illustration of four different
preparing routes of composite nanopowders based
on sol–gel method.

Results and discussion
XRD analyses

Figure 2 shows the XRD patterns of the synthesized
composite nanopowders. Since the bioactive glass
phase is amorphous, no related peak can be observed
in the XRD patterns. Thus the calculated fractions of
crystalline phase ( X c ) and crystallite size ( X s ) of the
HAp-BG nanopowders based on the diffraction peaks
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Fig. 2 XRD patterns of HAp-BG composite
nanopowders.

and using Scherrer’s formula respectively are listed in
Table 1. The XRD investigation reveals that the
fraction of crystalline phase of the final composite
nanopowders is affected by the sequence of adding
precursors. The crystallinity of the composite
decreases in the presence of bioactive glass as the
sintering temperature was set at 600 ℃ for all the
samples. Silicon-containing ionic products of the
bioactive glass can easily be released in the HAp sols.
Andersson et al. [21] reported that the presence of
silica in the solution slows down the HAp crystallite
growth. Compared to the pure HAp and HAp-BG
nanopowders, the composite nanopowders would be
restricted in the crystallization owing to silica which
acts as a barrier to crystallization against another phase
by limiting atomic arrangement [22]. It is worth noting
that the difference in crystallinity between HBIV
sample and the pure HAp reported by Latifi et al. [23],
is not distinct. Moreover, in situ synthesis (the HAp
solutions including BG, i.e., HBI, HBII and HBIII
samples) leads to decrease in the crystallite size of
HAp-BG nanopowders.
3. 2

FTIR spectroscopy

FTIR spectra of the prepared composite nanopowders
are presented in Fig. 3. The data obtained for bare pure
Table 1
Crystallinity and crystallite size of
hydroxyapatite with 20 wt% bioglass nanopowders
Sample
HBI
HBII
HBIII
HBIV

Crystallite size (nm)
28
55
54
58

Crystallinity (%)
65
66
66
70

Fig. 3
FTIR spectra of the hydroxyapatite
nanopowders and HAp-BG composite nanopowders.

HAp is also inserted in Fig. 3 for comparison. In
general, the spectra do not show significant differences
on absorption bands among the composite producing
procedures. For all the specimens, the characteristic
vibration bands of PO43− are observed at around
560–570 cm−1, 600–610 cm−1, 960–970 cm−1 and
1000–1100 cm−1, and OH− bands at around 460–
480 cm−1, 620–640 cm−1 and 3520–3530 cm−1, showing
typical HAp characteristics [16,24,25]. The bands at
3300–3400 cm−1 correspond to H–O–H from water
absorption of synthesis process [26]. A comparison
between pure HAp and HAp-BG composite IR spectra
shows that the intensity of characteristic bands
decreases in composite nanopowders, which could be
attributed to the presence of SiO2. In the composite
nanopowders, the absorption bands around 1000–
1100 cm−1 correspond to both P–O and Si–O–Si
groups. Furthermore, the absorption bands in the range
of 3200–3400 cm−1 indicating that the Si–OH groups
are present in the composite nanopowder lattice
structure [17,23]. It should be pointed out that HAp
and silica share a number of superimposed vibrational
bands, due to similarities of SiO44− and PO43− tetrahedral
molecular units [23,27]. Thus, it would be difficult to
distinguish SiO2 absorption bands because of stronger
overlapping absorption bands of HAp.
The characteristic bands of C–O group occur at
860–880 cm−1 and 1400–1450 cm−1. A band at about
875 cm−1 could be either CO32− or HPO42− groups. It
suggests that CO32− ions are partly substituted with
PO43− in the apatite structure and the amorphous
complex [23]. The CO32− ions may be resulted from the
incomplete pyrolysis of organic compounds or as a
common contaminant from the atmosphere. They
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possibly penetrate within the composite structure
during synthesis process [28,29]. The dissolution of
CO2 from the atmosphere occurs by the following
reaction:
CO 2 (g) + 2OH  (aq)  CO32  (aq) + H 2 O(l)
(4)
Since carbonated apatite is more similar to the bone
structure, the presence of CO32− may improve the
bioactivity of the composition [30,31].

3. 3

SEM and EDS evaluation

Figure 4 shows the morphological characteristics and
elemental analyses of the prepared composite
nanopowders. Large platelet or flake shape
agglomerates are formed in the HBI sample due to the
influence of short-range van der Waals forces during
aging [20,32]. The size distribution range of HBI
sample particles is approximately 10–300 nm. By
changing the synthesis process of composite
nanopowders, the plate like aggregates are converted
into more uniform distribution of particles, especially
for HBII and HBIII samples. The particle size
distributions of the HBII, HBIII and HBIV samples are
approximately achieved in the range of 15–130 nm,
10–150 nm and 20–350 nm, respectively. Thus, HBIV
sample has greater size of agglomerates. This
observation could be explained by milling process.
During the initial stage of milling, the rate of
agglomeration is higher than that of fragmentation of
fine particles due to higher rate of cold welding [33].
Generally speaking, the SEM micrographs of all the
samples show that plenty of significantly fine particles
are interconnected and form irregular agglomerated

211

clusters.
It should be noted that the fine and homogeneous
microstructure is the initial important factor for
improvement in mechanical properties and biomedical
performance of bulk ceramics [34,35].
It has been demonstrated that the morphology and
the degree of aggregation are attributed to the
concentration and the rate of mixing applied to the
solutions. From the view of the mentioned observation,
it is expected that since the concentration of primary
solutions and the mixing speed of the precursors are
low, the final powders are toward the formation of
non-agglomerated particles [28], while our observation
reveals that the overall mixing procedure is another
important factor which determines the morphological
characteristics.
Since the bioglass nanopowders are added within the
hydroxyapatite solution (HBII and HBIII samples), the
HAp nanoparticles start to deposit on the surface of the
heterogeneous nucleation sites [36]. It is confirmed
that SiO2 in the bioglass structure can inhibit the HAp
particle growth [21,28]. Thus, fine and well distributed
spherical shape is produced in the HBII and HBIII
samples.
As shown in Fig. 4, the existence of Ca, P, O and Si
in the EDS analysis is related to hydroxyapatite and
bioactive glass. The EDS result confirms that a
homogeneous distribution of components is formed
during synthesis. As expected, the elemental
components of all the samples are almost the same.
EDS analysis also gives the insight into the variations
in the composition of Ca/P ratios of the prepared
composite nanopowders. Because of the presence of

Fig. 4 SEM micrographs and EDS analyses of the ((a) and (b)) HBI, ((c) and (d)) HBII, ((e) and (f)) HBIII, and
((g) and (h)) HBIV samples.
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Ca and P in bioactive glass precursors, the ratio of
Ca/P is higher than that in pure HAp (> 1.67).
Moreover, the Ca/P contents vary in each sample
suggesting that the synthesis process modifies the Ca/P
ratio.

3. 4

TEM analysis

To get a clear insight into the nanostructure nature of
the produced composites and also to investigate the
particle morphologies, TEM micrographs are provided
as shown in Fig. 5. All the samples show nano-sized
spheroidal morphology. The powders show a
cluster-like structure which is composed of several
small particles in the range of 20–60 nm. The
agglomerate particles are hard to break down even
with long time ultrasonication, especially for HBI and
HBII particles. The formation of agglomerated
particles can be explained by different possible
reaction mechanisms in various synthesis scripts [31].
This confirms the changes in the morphology of the
composite nanopowders.

3. 5

BET and average grain size

The specific surface area (SSA) values of the
composite nanopowders are presented in Table 2. The
results of the average particle size (DBET )
measurements on these samples are also given. It

Table 2 Specific surface area (SSA) and average
particle size ( DBET ) of hydroxyapatite with
20 wt% bioglass nanopowders
Sample
HBI
HBII
HBIII
HBIV

Specific surface
area (m2/g)
65.49
33.56
40.73
32.40

Equivalent spherical
particle diameter (nm)
32.72
63.85
52.60
66.12

should be noted that the aggregation of the powders
decreases the specific surface area [37]. The calculated
DBET ranges between 30 nm and 70 nm. The results
are in good agreement with TEM observations and the
mean crystallite size determined by XRD. A slight
difference between these results is due to assumption
of powders to be spherical in BET method. According
to the previous investigations, decreasing particle size
through increasing the specific surface area would
increase the interaction between the material and the
physiological solution, and therefore, enhances the
kinetics of bioactivity reactions, e.g., osteoblast
functions and protein adsorption [38–40].
As a result, we conclude that a reduction of the
specific surface area is supported by cluster-like
structure formed during powder synthesis methods.
Current study has led to the refinement and
optimization in the particle size, particle size

Fig. 5 TEM micrographs of (a) HBI, (b) HBII, (c) HBIII and (d) HBIV samples.
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distribution, and degree of particle agglomeration of
the HAp-BG composite nanopowders, which are
important factors in the selection of the most
appropriate biomaterials during tissue interactions. In
the next article we will describe our research efforts in
two-step sintering process on consolidation of
bioactive glass content on sinter-ability, mechanical
properties, and bioactivity of hydroxyapatite bulks.

4 Conclusions
In the present study, a comparative study of sol–gel
derived hydroxyapatite-bioglass (HAp-BG) composite
nanopowders reveals that a number of desirable
features in biomaterials can be easily controlled with
different processing histories. A uniform microstructure
with fine grain size and well distribution is observed
for material obtained from route-III processed powders
(mixing calcined BG nanopowders with HAp solution),
whereas a significant tendency to agglomeration is
observed in other powders. The high efficiency of the
process opens a way to produce commercial amount of
HAp-BG nanopowders. The material can be compacted
and transformed in solid HAp-BG ceramic samples
which emerge the potential ability to induce bone
regeneration when implanted heterotopically. Although
further improvements to the HAp-BG composite are
necessary, this is a promising first investigation
showing its inherent ability to develop in hard tissue
applications from the mechanical and biological
perspectives.
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